莫西沙星对贝氏柯克斯体的抑菌和杀菌活性。
Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii.
作者信息
Rolain J M, Maurin M, Raoult D
机构信息
Unité des Rickettsies CNRS UPRES-A 6020, Faculté de Médecine, Université de la Méditerranée, 13385 Marseille Cedex 05, France.
出版信息
Antimicrob Agents Chemother. 2001 Jan;45(1):301-2. doi: 10.1128/AAC.45.1.301-302.2001.
Abstract
The in vitro activity of moxifloxacin against Coxiella burnetii was compared to those of pefloxacin, ofloxacin, and doxycycline. MICs of moxifloxacin ranged from 0.5 to 1 microg/ml for the Nine Mile, Priscilla, and Q212 strains. Moxifloxacin was not bactericidal against C. burnetii at 4 microg/ml.
摘要
将莫西沙星对伯氏考克斯体的体外活性与培氟沙星、氧氟沙星和多西环素进行了比较。莫西沙星对Nine Mile、Priscilla和Q212菌株的最低抑菌浓度（MIC）范围为0.5至1微克/毫升。莫西沙星在4微克/毫升时对伯氏考克斯体无杀菌作用。
相似文献
1
Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii.
Antimicrob Agents Chemother. 2001 Jan;45(1):301-2. doi: 10.1128/AAC.45.1.301-302.2001.
2
In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.
Antimicrob Agents Chemother. 2001 Nov;45(11):3276-8. doi: 10.1128/AAC.45.11.3276-3278.2001.
3
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.
Antimicrob Agents Chemother. 1998 Oct;42(10):2747-8. doi: 10.1128/AAC.42.10.2747.
4
In vitro susceptibility of Coxiella burnetii to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones.
Int J Antimicrob Agents. 2004 Aug;24(2):194-6. doi: 10.1016/j.ijantimicag.2004.05.001.
5
Cure of Q fever pneumonia with moxifloxacin: case report.
Scand J Infect Dis. 2005;37(10):778-80. doi: 10.1080/00365540510037858.
6
Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, 'Israeli spotted fever group rickettsia' and Coxiella burnetii.
J Antimicrob Chemother. 1997 Jun;39(6):725-30. doi: 10.1093/jac/39.6.725.
7
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
Antimicrob Agents Chemother. 2009 Jun;53(6):2690-2. doi: 10.1128/AAC.01424-08. Epub 2009 Mar 30.
8
In vitro activities of moxifloxacin and other fluoroquinolones against Mycoplasma pneumoniae.
Antimicrob Agents Chemother. 2001 Jun;45(6):1908-10. doi: 10.1128/AAC.45.6.1908-1910.2001.
9
Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.
Antimicrob Agents Chemother. 2001 Mar;45(3):673-8. doi: 10.1128/AAC.45.3.673-678.2001.
10
Susceptibility of Rickettsia conorii, R. rickettsii, and Coxiella burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin.
Antimicrob Agents Chemother. 1992 Nov;36(11):2529-32. doi: 10.1128/AAC.36.11.2529.
引用本文的文献
1
Evaluation of the Efficacy of Doxycycline, Ciprofloxacin, Levofloxacin, and Co-trimoxazole Using and Models of Q Fever.
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0067321. doi: 10.1128/AAC.00673-21. Epub 2021 Aug 9.
2
Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells.
mSphere. 2021 Aug 25;6(4):e0044221. doi: 10.1128/mSphere.00442-21. Epub 2021 Jul 7.
3
Doxycycline desensitization in chronic Q fever-A critical tool for the clinician.
IDCases. 2018 Feb 20;11:70-72. doi: 10.1016/j.idcr.2018.01.006. eCollection 2018.
4
Antimicrobial therapies for Q fever.
Expert Rev Anti Infect Ther. 2013 Nov;11(11):1207-14. doi: 10.1586/14787210.2013.840534. Epub 2013 Sep 27.
5
Emergence of q Fever.
Iran J Public Health. 2011;40(3):1-18. Epub 2011 Sep 30.
6
Pentamidine inhibits Coxiella burnetii growth and 23S rRNA intron splicing in vitro.
Int J Antimicrob Agents. 2010 Oct;36(4):380-2. doi: 10.1016/j.ijantimicag.2010.05.017.
7
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
Antimicrob Agents Chemother. 2009 Jun;53(6):2690-2. doi: 10.1128/AAC.01424-08. Epub 2009 Mar 30.
8
Diffuse abdominal uptake mimicking peritonitis in gallium inflammatory scan: an unusual feature of acute Q fever.
Kaohsiung J Med Sci. 2005 Nov;21(11):522-6. doi: 10.1016/S1607-551X(09)70161-5.
9
Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis.
Antimicrob Agents Chemother. 2005 Jul;49(7):2673-6. doi: 10.1128/AAC.49.7.2673-2676.2005.
本文引用的文献
1
Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.
J Antimicrob Chemother. 1999 Dec;44(6):835-8. doi: 10.1093/jac/44.6.835.
2
Q fever.
Clin Microbiol Rev. 1999 Oct;12(4):518-53. doi: 10.1128/CMR.12.4.518.
3
Activity of grepafloxacin and other fluoroquinones and newer macrolides against recent clinical isolates of Chlamydia pneumoniae.
Int J Antimicrob Agents. 1999 Jul;12(2):181-4. doi: 10.1016/s0924-8579(99)00057-6.
4
Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone.
J Antimicrob Chemother. 1999 May;43 Suppl B:91-100. doi: 10.1093/jac/43.suppl_2.91.
5
Moxifloxacin.
Drugs. 1999 Mar;57(3):363-73; discussion 374. doi: 10.2165/00003495-199957030-00007.
6
Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells.
Antimicrob Agents Chemother. 1999 Jan;43(1):12-5. doi: 10.1128/AAC.43.1.12.
7
In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin.
Antimicrob Agents Chemother. 1998 Oct;42(10):2747-8. doi: 10.1128/AAC.42.10.2747.
8
Susceptibilities of Legionella spp. to newer antimicrobials in vitro.
Antimicrob Agents Chemother. 1998 Jun;42(6):1520-3. doi: 10.1128/AAC.42.6.1520.
9
In vitro activity of BAY 12-8039, a new fluoroquinolone against mycoplasmas.
Antimicrob Agents Chemother. 1998 Mar;42(3):703-4. doi: 10.1128/AAC.42.3.703.
10
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone.
Antimicrob Agents Chemother. 1997 Aug;41(8):1818-24. doi: 10.1128/AAC.41.8.1818.
Zotero 插件